Home › Endometrial Cancer › Maine
Endometrial Cancer clinical trials in Maine
8 studies for Endometrial Cancer are looking for participants at sites in Maine.
Cities in Maine
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- Lafayette Family Cancer Center-EMMC, Brewer
- MaineHealth Maine Medical Center- Scarborough, Scarborough
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 30, 2026 · NCT07198074Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
- Harold Alfond Center for Cancer Care, Augusta
- MaineHealth Maine Medical Center- Scarborough, Scarborough
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 29, 2026 · NCT05256225Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Harold Alfond Center for Cancer Care, Augusta
- Lafayette Family Cancer Center-EMMC, Brewer
- MaineHealth Maine Medical Center- Scarborough, Scarborough
- and 1 more
RecruitingPhase 2
All ages · All sexes · Updated Sep 29, 2026 · NCT05564377Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- MaineHealth Maine Medical Center- Scarborough, Scarborough
RecruitingPhase 2
Ages 18 and older · Women · Updated Sep 28, 2026 · NCT05112601A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Maine Medical Center - Scarborough Campus ( Site 6042), Scarborough
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 17, 2026 · NCT06952504Endometrial Cancer Vaginal Fluid Specimen Collection Study
- MaineHealth, Scarborough
RecruitingObservational study
Ages 18 and older · Women · Updated Aug 27, 2026 · NCT07544680Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Scarborough
RecruitingPhase 3
Ages 18 and older · Women · Updated Jul 29, 2026 · NCT07044336SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Scarborough
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.